Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.

Volume 3 (2007), Issue 12 (December)

1. A comparison of community pharmacists' views of over-the-counter omeprazole and simvastatin.
   Pharmacoepidemiol Drug Saf, 16(12): 1290-7. [Abstract] [Full-text]
2. Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses.
   Pharmacoepidemiol Drug Saf, 16(12): 1268-72. [Abstract] [Full-text]
3. Surface tension and rheology of aqueous dispersed systems containing a new hydrophobically modified polymer and surfactants.
   Int J Pharm, 347(1): 45-53. [Abstract] [Full-text]
4. Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
   Breast Cancer Res Treat. [Abstract] [Full-text]
5. Advance provision of emergency contraception for pregnancy prevention: a meta-analysis.
   Obstet Gynecol, 110(6): 1379-88. [Abstract] [Full-text]
6. Intimate partner violence and health care costs and utilization for children living in the home.
   Pediatrics, 120(6): 1270-7. [Abstract] [Full-text]
7. Self-monitoring of blood pressure and the role of community pharmacists in Kuwait.
   Med Princ Pract, 17(1): 27-31. [Abstract] [Full-text]
8. Concordance of Medicaid and pharmacy record data in inner-city children with asthma.
   Contemp Clin Trials, 29(1): 13-20. [Abstract] [Full-text]
9. Drug costs and out-of-pocket spending in cancer clinical trials.
   Contemp Clin Trials, 29(1): 1-8. [Abstract] [Full-text]
10. Prescription opioid use, misuse, and diversion among street drug users in New York City.
    Drug Alcohol Depend, 92(1): 267-76. [Abstract] [Full-text]
11. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
    Int Arch Occup Environ Health. [Abstract] [Full-text]
12. Investigating the relationship between the practice of pharmaceutical care, construed external image, organizational identification, and job turnover intention of community pharmacists.
    Res Social Adm Pharm, 3(4): 438-63. [Abstract] [Full-text]
13. Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
    Res Social Adm Pharm, 3(4): 410-25. [Abstract] [Full-text]
14. Utilization patterns and medication adherence in patients with type 2 diabetes: Variations based on type of pharmacy (chain vs independent).
    Res Social Adm Pharm, 3(4): 378-91. [Abstract] [Full-text]
15. Relationships between multiple self-reported nonadherence measures and pharmacy records.
    Res Social Adm Pharm, 3(4): 363-77. [Abstract] [Full-text]
16. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
    Aust N Z J Public Health, 31(6): 533-9. [Abstract] [Full-text]
17. Safe storage of methadone takeaway doses - a survey of patient practice.
    Aust N Z J Public Health, 31(6): 526-8. [Abstract] [Full-text]
18. Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies.
    Aust N Z J Public Health, 31(6): 516-9. [Abstract] [Full-text]
19. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
    Curr Med Res Opin, 23(12): 3137-52. [Abstract] [Full-text]
20. Barriers to the initiation of, and persistence with, insulin therapy.
    Curr Med Res Opin, 23(12): 3105-12. [Abstract] [Full-text]
21. A cross-national study of the persistence of antihypertensive medication use in the elderly.
    J Hypertens, 26(1): 145-53. [Abstract] [Full-text]
22. Human resources requirements for highly active antiretroviral therapy scale-up in Malawi.
    BMC Health Serv Res, 7(1): 208. [Abstract] [Full-text]
23. A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States.
    Appl Radiat Isot, 66(2): 252-60. [Abstract] [Full-text]
24. Does spatial accessibility of pharmacy services predict compliance with long-term control medications?
    J Asthma, 44(10): 881-3. [Abstract] [Full-text]
25. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones.
    Eur Urol, 53(2): 411-8. [Abstract] [Full-text]
26. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
    Pharmacoepidemiol Drug Saf, 17(1): 82-9. [Abstract] [Full-text]
27. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy-a descriptive study.
    Pharmacoepidemiol Drug Saf, 17(1): 52-61. [Abstract] [Full-text]
28. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients.
    Pharmacoepidemiol Drug Saf, 17(1): 27-36. [Abstract] [Full-text]
29. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology.
    Pharmacotherapy, 28(1): 1-13. [Abstract] [Full-text]
30. The demand for statin: the effect of copay on utilization and compliance.
    Health Econ, 17(1): 83-97. [Abstract] [Full-text]
31. Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction.
    J Cardiovasc Nurs, 23(1): 14-9. [Abstract] [Full-text]
32. Sacral neuromodulation: cost considerations and clinical benefits.
    Urology, 70(6): 1069-73; discussion 1073-4. [Abstract] [Full-text]
33. Beliefs about medicines predict refill adherence to inhaled corticosteroids.
    J Psychosom Res, 64(1): 47-54. [Abstract] [Full-text]
34. Variation in medication information for elderly patients during initial interventions by emergency department physicians.
    Am J Health Syst Pharm, 65(1): 60-4. [Abstract] [Full-text]
35. Enhanced photoemission spectroscopy for verification of high-risk i.v. medications.
    Am J Health Syst Pharm, 65(1): 49-54. [Abstract] [Full-text]
36. Medicaid preferred drug lists' costs to physicians.
    Med Care, 46(1): 9-16. [Abstract] [Full-text]
37. What do different databases tell about the use of opioids in seven European countries in 2002?
    Eur J Pain. [Abstract] [Full-text]
38. Clinical and demographic characteristics help explain variations in pain at the end of life.
    J Pain Symptom Manage, 35(1): 10-9. [Abstract] [Full-text]
39. Emergency contraception update: a Canadian perspective.
    Clin Pharmacol Ther, 83(1): 177-80. [Abstract] [Full-text]
40. Towards the reduction of medication errors in orthopedics and spinal surgery: outcomes using a pharmacist-led approach.
    Spine, 33(1): 104-7. [Abstract] [Full-text]
41. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market-Consequences for costs and availability.
    Health Policy. [Abstract] [Full-text]
42. Intrathecal pumps.
    Neurotherapeutics, 5(1): 114-22. [Abstract] [Full-text]
43. A systematic review of low back pain cost of illness studies in the United States and internationally.
    Spine J, 8(1): 8-20. [Abstract] [Full-text]
44. Iatrogenic disease management: moderating medication errors and risks in a pharmacy benefit management environment.
    Dis Manag, 10(6): 337-46. [Abstract] [Full-text]

© 2005-2008 Pharmacy Research Today. All Rights Reserved.